Hovione Technology, a subsidiary of CDMO Hovione, announced that it has been granted a patent on a new method of particle size analysis that provides improved sample preparation for more accurate measurements and better repeatability. Hovione Technology primarily focuses on dry powder inhaler devices, including the 8Shot large dose DPI, the TwinMax DPI, the Papillon DPI, and the PowdAir Plus DPI.
Hovione Director of Analytical Development Constança Cacela explained, “For years we had problems where the same batch of powder gave different results when tested in different laser diffraction testing machines and this led to serious issues and challenges during method transfer. Drugs known to agglomerate, particularly fine powders used for inhaled pulmonary delivery, were a problem to test. We have implemented the improved method in different machines of different analytical laboratories and everyone is now getting the same test data.”
Hovione Technology CEO Peter Villax commented, “We saw the IP potential of Hovione’s invention and went ahead with patent filing and prosecution. Even though our application went through vigorous scrutiny and an objection from a third party, it has now proceeded to grant in all jurisdictions where it was filed. These patents are now being offered for licensing to several manufacturers of laser diffraction particle sizing machines and they could have an impact on this market.”
Read the Hovione Technology press release.
